NCT04373265 2024-02-23
Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol)
Corcept Therapeutics
Phase 1 Completed
Corcept Therapeutics
Seoul National University Hospital
Suez Canal University
M.D. Anderson Cancer Center